Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs)

• Main Authors: Maosheng Chen (Author), Jing Peng (Author), Qi Xie (Author), Na Xiao (Author), Xian Su (Author), Hua Mei (Author), Yeping Lu (Author), Jia Zhou (Author), Yanni Dai (Author), Siqi Wang (Author), Chuang Li (Author), Ge Lin (Author), Lamei Cheng (Author)
• Format: Book
• Published: Hindawi Limited, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The anti-inflammatory and immunomodulatory properties of mesenchymal stem cells (MSCs) have been proposed to be involved in some autoimmune diseases and have been successfully tested in patients and mice. But their contribution to psoriasis and the underlying mechanisms involved remains elusive. Her...